• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Enzymuria: a parameter for the assessment of potential nephrotoxicity of cephalosporins.

作者信息

Mondorf A W, Scherberich J E, Heinert G, Schoeppe W

出版信息

J Antimicrob Chemother. 1983 Jul;12 Suppl A:251-4. doi: 10.1093/jac/12.suppl_a.251.

DOI:10.1093/jac/12.suppl_a.251
PMID:6137472
Abstract

Ten informed healthy volunteers with normal renal function received 2 X 3.0 g ceftazidime on three consecutive days. The combination of the same dose of ceftazidime together with tobramycin (3 mg/kg/d) was administered four weeks later to the same group of volunteers. In the first trial with ceftazidime alone no changes in the elimination of brush-border membrane enzyme AAP were found. In contrast, the administration of ceftazidime together with tobramycin produced the expected response to tobramycin with the cumulative pattern of enzyme elimination into urine. Functional parameters remained unchanged.

摘要

相似文献

1
Enzymuria: a parameter for the assessment of potential nephrotoxicity of cephalosporins.
J Antimicrob Chemother. 1983 Jul;12 Suppl A:251-4. doi: 10.1093/jac/12.suppl_a.251.
2
Assessment of the nephrotoxic potential of ceftazidime and a ceftazidime/tobramycin combination in volunteers.评估头孢他啶及头孢他啶/妥布霉素联合用药对志愿者的肾毒性潜力。
Infection. 1983;11 Suppl 1:S57-62. doi: 10.1007/BF01641109.
3
Enzymuria in neonates during treatment with tobramycin or ceftazidime.新生儿在接受妥布霉素或头孢他啶治疗期间出现酶尿。
Pediatr Infect Dis J. 1988 Feb;7(2):142-3. doi: 10.1097/00006454-198802000-00019.
4
Tobramycin nephrotoxicity: failure of cefotaxime to potentiate renal toxicity.
Infection. 1982;10(4):233-9. doi: 10.1007/BF01666917.
5
Urinary alanine-aminopeptidase (AAP) excretion in patients with urinary tract infection treated with ceftazidime (CAZ) or cefotaxime (CTX) plus tobramycin (TOB).接受头孢他啶(CAZ)或头孢噻肟(CTX)加妥布霉素(TOB)治疗的尿路感染患者的尿丙氨酸氨基肽酶(AAP)排泄情况。
Int Urol Nephrol. 1988;20(5):461-70. doi: 10.1007/BF02550604.
6
Tubular-toxic effects of aminoglycosides and their combinations with cephalosporins.
Curr Probl Clin Biochem. 1979(9):192-200.
7
A multiple-center comparative study of the kidney tolerance of ceftazidime versus cefotaxime and tobramycin.头孢他啶与头孢噻肟及妥布霉素肾脏耐受性的多中心比较研究
Chemioterapia. 1987 Jun;6(2 Suppl):331-2.
8
Ceftazidime nephrotoxicity in rats.头孢他啶对大鼠的肾毒性。
Antimicrob Agents Chemother. 1984 Apr;25(4):513-4. doi: 10.1128/AAC.25.4.513.
9
[Kidney tolerance of fosfomycin in humans with normal kidney function (author's transl)].正常肾功能人群中磷霉素的肾脏耐受性(作者译)
Immun Infekt. 1981 Jul;9(4):147-9.
10
[Comparative studies on the action of aminoglycosides and cephalosporins on the proximal tubule of the human kidney (author's transl)].
Nouv Presse Med. 1978 Nov 29;7(42):3835-7.

引用本文的文献

1
Urinary alanine-aminopeptidase (AAP) excretion in patients with urinary tract infection treated with ceftazidime (CAZ) or cefotaxime (CTX) plus tobramycin (TOB).接受头孢他啶(CAZ)或头孢噻肟(CTX)加妥布霉素(TOB)治疗的尿路感染患者的尿丙氨酸氨基肽酶(AAP)排泄情况。
Int Urol Nephrol. 1988;20(5):461-70. doi: 10.1007/BF02550604.
2
Seasonal effects on the daily variations of gentamicin-induced nephrotoxicity.庆大霉素诱导的肾毒性每日变化的季节效应。
Arch Toxicol. 1990;64(3):205-9. doi: 10.1007/BF02010726.